BORIANI, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 21.154
EU - Europa 18.789
AS - Asia 15.872
SA - Sud America 1.178
AF - Africa 1.004
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 11
Totale 58.035
Nazione #
US - Stati Uniti d'America 21.025
GB - Regno Unito 5.283
SG - Singapore 4.661
VN - Vietnam 4.357
CN - Cina 4.072
IT - Italia 3.047
DE - Germania 2.842
UA - Ucraina 1.935
SE - Svezia 1.193
RU - Federazione Russa 1.128
HK - Hong Kong 1.043
IN - India 1.003
BR - Brasile 895
NL - Olanda 878
FR - Francia 861
IE - Irlanda 577
EE - Estonia 446
ZA - Sudafrica 377
JP - Giappone 326
CI - Costa d'Avorio 237
SC - Seychelles 171
FI - Finlandia 157
AR - Argentina 132
TG - Togo 119
KR - Corea 115
CH - Svizzera 74
CA - Canada 70
BG - Bulgaria 69
BE - Belgio 55
JO - Giordania 53
AT - Austria 47
MX - Messico 46
GR - Grecia 45
NG - Nigeria 45
EC - Ecuador 44
ID - Indonesia 41
IR - Iran 38
PL - Polonia 37
BD - Bangladesh 28
CL - Cile 28
LB - Libano 26
PY - Paraguay 25
UZ - Uzbekistan 24
CO - Colombia 23
ES - Italia 20
TR - Turchia 19
AU - Australia 18
RO - Romania 17
CZ - Repubblica Ceca 15
EG - Egitto 14
HR - Croazia 14
IQ - Iraq 14
MY - Malesia 12
UY - Uruguay 12
MA - Marocco 11
PE - Perù 10
EU - Europa 7
KZ - Kazakistan 7
NZ - Nuova Zelanda 7
DK - Danimarca 6
KE - Kenya 6
SN - Senegal 6
VE - Venezuela 6
AL - Albania 5
AZ - Azerbaigian 5
DO - Repubblica Dominicana 5
SK - Slovacchia (Repubblica Slovacca) 5
TN - Tunisia 5
HN - Honduras 4
HU - Ungheria 4
LU - Lussemburgo 4
NO - Norvegia 4
PK - Pakistan 4
PT - Portogallo 4
SA - Arabia Saudita 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AE - Emirati Arabi Uniti 3
BY - Bielorussia 3
DZ - Algeria 3
LT - Lituania 3
TH - Thailandia 3
AM - Armenia 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
IL - Israele 2
KW - Kuwait 2
LK - Sri Lanka 2
MD - Moldavia 2
ML - Mali 2
MU - Mauritius 2
RS - Serbia 2
SI - Slovenia 2
SR - Suriname 2
SV - El Salvador 2
TW - Taiwan 2
AD - Andorra 1
AF - Afghanistan, Repubblica islamica di 1
BO - Bolivia 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
Totale 58.023
Città #
Southend 4.731
Singapore 2.998
Fairfield 2.538
Ashburn 1.888
Jacksonville 1.378
Wilmington 1.283
Woodbridge 1.166
Seattle 1.144
Princeton 1.112
Chandler 1.098
Houston 1.069
Hong Kong 1.038
Cambridge 869
Ho Chi Minh City 798
Dong Ket 788
Santa Clara 786
Ann Arbor 659
Kerkrade 652
Hanoi 615
Boardman 597
Dublin 576
Westminster 506
Padova 505
Nanjing 487
Beijing 405
Frankfurt am Main 389
Hefei 340
Tokyo 318
Berlin 308
Los Angeles 281
Medford 255
Saint Petersburg 254
Milan 246
Jinan 242
Abidjan 237
Shenyang 228
Mülheim 215
Buffalo 213
San Diego 188
Changsha 173
Bologna 171
Mahé 160
Hebei 157
Nanchang 147
Helsinki 141
Rome 137
Bremen 122
Dallas 120
Lomé 119
Redondo Beach 119
New York 118
Turin 118
Tianjin 106
Seoul 105
Jiaxing 102
Guangzhou 93
São Paulo 89
Olalla 88
Des Moines 85
Verona 82
Hangzhou 79
Yubileyny 78
Shanghai 76
Zhengzhou 76
Haiphong 73
Norwalk 73
Da Nang 69
Dearborn 66
Ningbo 66
Sofia 63
Falls Church 58
Haikou 58
Munich 58
Biên Hòa 54
Amman 53
Brussels 51
Mountain View 48
Ha Long 45
Chicago 44
Ninh Bình 44
San Venanzo 44
Florence 43
Taizhou 43
Abeokuta 42
Hải Dương 42
Lanzhou 42
London 42
Bengaluru 40
Bern 40
Bühl 38
Kunming 38
Phoenix 37
Taiyuan 37
Bari 36
Vũng Tàu 36
Fuzhou 35
Nuremberg 35
Thái Nguyên 35
Falkenstein 33
Quận Bình Thạnh 33
Totale 37.955
Nome #
'Real-World' antithrombotic treatment in atrial fibrillation: The eorp-af pilot survey 1.246
Incremento dei valori di troponina T dopo impianto di pacemaker con elettrodi a fissaggio attivo e passivo. 1.027
Psychological correlates, allostatic overload and clinical course in patients with implantable cardioverter defibrillator (ICD) 312
Cardiac Resynchronization Therapy in Patients With Atrial Fibrillation 304
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA) 271
Delayed asymptomatic migration of an implantable cardioverter-defibrillator lead to the costophrenic angle. 267
Incidenza e fattori predittivi di fibrillazione atriale post operatoria nei riceventi di trapianto renale 259
Acute and chronic haemodynamic effects of biventricular pacing and of switching to different pacing modalities in heart failure patients 255
Resynchronization for HemodYnamic Treatment for Heart Failure Management II (RHYTHM II) Investigators. A prospective randomized evaluation of VV delay optimization in CRT-D recipients:echocardiographic observations from the RHYTHM II ICD study. 251
Effects of cardiac resynchronization therapy on coronary blood flow: evaluation by transthoracic Doppler echocardiography. Poster European Congress of Cardiology 2007 241
11C-mHED for PET / CT: principles of synthesis, methodology and first clinical applications 226
Actual pacemaker longevity: the benefit of stimulation by automatic capture verification. 222
Changes in exercise capacity induced by heart transplantation: prognostic and therapeutic implications. 222
Atrial fibrillation: it is better to be alone than in bad company! 217
P wave dispersion and short-term vs. late atrial fibrillation recurrences after cardioversion. 214
Fattori predittivi di rimodellamento cardiaco inverso del ventricolo sinistro in pazienti candidati a terapia di resincronizzazione cardiaca: il ruolo dell’eziologia. 209
Aritimie cardiache, morte cardiaca improvvisa, sincope 200
Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy. 196
AF burden is important - Fact or fiction? 195
The Drug And Pace Health cliNical Evaluation (DAPHNE) study: A randomized trial comparing sotalol versus β-blockers to treat symptomatic atrial fibrillation in patients with brady-tachycardia syndrome implanted with an antitachycardia pacemaker 193
Arrhythmia discrimination by physician and defibrillator: importance of atrial channel. 189
La tachicardiomiopatia: una revisione della letteratura 188
A changing scenario in the clinical use of implantable defibrillators: the need for long-term data on lead performance. 187
Switching among Equivalents in Chronic Cardiovascular Therapies: 'Real World' Data from Italy 187
From lead management to implanted patient management: indications to lead extraction in pacemaker and cardioverter-defibrillator systems 186
Balancing the risk of hemorrhage vs thromboembolism in patients with atrial fibrillation: how to navigate between Scylla and Charybdis? 185
Cardiac resynchronization therapy: variations in echo-guided optimized atrioventricular and interventricular delays during follow-up. 184
Asymptomatic Atrial Fibrillation: Clinical Correlates, Management, and Outcomes in the EORP-AF Pilot General Registry 183
Electrocardiographic remodeling during cardiac resynchronization therapy 182
Amyloid deposition as a cause of atrial remodelling in persistent valvular atrial fibrillation 180
Automatic verification of ventricular stimulation: fusion management algorithm 177
Assessment of regional left ventricular function by radionuclide angiography in CRT patients. Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques. 175
Battery drain in daily practice and medium-term projections on longevity of cardioverterdefibrillators: An analysis from a remote monitoring database 174
Biventricular ICDs and rhythm discrimination by analysis of QRS morphology: are there QRS changes associated with left ventricular reverse remodeling? Poster European Congress of Cardiology 2007 173
Atrial fibrillation ablation: beyond electro-mechanical matters 171
Heart rate variability monitored by the implanted device predicts response to CRT and long-term clinical outcome in patients with advanced heart failure. 170
Acute changes in electromechanical parameters during different pacing configurations using a quadripolar left ventricular lead 169
Cardiac resynchronization therapy: a comparison among left ventricular bipolar, quadripolar and active fixation leads 165
How to truly value implantable cardioverter-defibrillators technology: Up-front cost or daily cost? 165
Solution to a crushing dosage problem? 164
Incidence and Predictors of Postoperative Atrial Fibrillation in Kidney Transplant Recipients. 164
Rate control in AFFIRM: considerations about the clinical implications. 163
Automatic management of left ventricular stimulation: hints for technologic improvement. 163
Pharmacological cardioversion of atrial fibrillation : current management and treatment options. 162
A comparison among three different echocardiographic methods for Interventricular delay optimization. Poster European Congress of Cardiology 2008 161
Wide spectrum of presentation and variable outcomes of isolated left ventricular non-compaction 160
Atrial fibrillation in heart failure patients undergoing resynchronization therapy: what decision making? Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques 160
Long-Term Implications of Atrial Fibrillation in Patients With Degenerative Mitral Regurgitation 160
Implications of cardiac resynchronization therapy and prophylactic defibrillator implantation among patients eligible for heart transplantation 160
Clinical implications of left superior vena cava persistence in candidates for pacemaker or cardioverter-defibrillator implantation 159
Prognostic implications of the Doppler restrictive filling pattern in hypertrophic cardiomyopathy 159
Exercise stress echocardiography is superior to rest echocardiography in predicting left ventricular reverse remodelling and functional improvement after cardiac resynchronization therapy. 158
Pacing with capture verification in candidates for resynchronisation therapy: a feasibility study. 157
Characteristics of ventricular tachyarrhythmias occurring in ischemic versus nonischemic patients implanted with a biventricular cardioverter-defibrillator for primary or secondary prevention of sudden death. 157
A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the RELEVANT [Role of long dEtection window programming in patients with LEft VentriculAr dysfunction, Non-ischemic eTiology in primary prevention treated with a biventricular ICD] study. 157
How, why, and when may atrial defibrillation find a specific role in implantable devices? A clinical viewpoint. 156
The MINERVA study design and rationale: a controlled randomized trial to assess the clinical benefit of minimizing ventricular pacing in pacemaker patients with atrial tachyarrhythmias. 156
Heart failure after myocardial revascularization: Risk markers. 155
Evaluation of fusion beat detection with a new ventricular automatic capture algorithm in ICDs. 155
Role of 18F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: A prospective study 155
Dilated-Hypokinetic evolution of hypertrophic cardiomyopathy 154
Biventricular Pacing: Electrocardiographic Versus Structural Remodeling 152
Can we improve risk stratification for thromboembolic events in atrial fibirillation by combining arrhythmia presence and duration with CHADS2 score? Poster European Congress of Cardiology 2008 152
Fibrillazione atriale e terapia di resincronizzazione cardiaca: quale strategia? 152
Resincronizzazione cardiaca con pacing biventricolare o ventricolare sinistro: effetti a medio termine su funzione sistolica e sincronia ventricolare sinistra 151
Transcatheter aortic valve implantation with a self-expanding nitinol bioprosthesis: prediction of the need for permanent pacemaker using simple baseline and procedural characteristics. 151
Implantation of cardioverter-defibrillator: Effects on shoulder function. 151
Antiarrhythmic effect of reverse ventricular remodeling induced by cardiac resynchronization therapy: the InSync ICD (Implantable Cardioverter-Defibrillator) Italian Registry. 150
Automatic management of atrial and ventricular stimulation in a contemporary unselected population of pacemaker recipients: the ESSENTIAL Registry 150
Analisi costi-benefici dell’impianto di cardioverter-defibrillatore 149
Effects of cardiac resynchronisation therapy on dilated cardiomyopathy with isolated ventricular non-compaction. 149
Effects of cardiac resynchronization therapy on diastolic function: evaluation by radionuclide angiography. 149
A prospective randomized evaluation of VV delay optimization in CRT patients. Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques. 148
Management of Phrenic Stimulation in CRT Patients over the Long Term: Still an Unmet Need ? 148
Cardiac resynchronization therapy in clinical practice: Need for electrical, mechanical, clinical and logistic synchronization. 148
Troponin I rise after pacemaker implantation at the time of "universal definition of myocardial infarction" 147
Cardioversione atriale interna: valutazione prospettica dei fattori determinanti il dolore indotto dallo shock. 146
Resolution of atrial thrombosis with heparin in a newborn with atrial flutter 146
'Real-world' management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: The EURObservational Research Programme-Atrial Fibrillation (EORP-AF) General Pilot Registry 146
Automatic management of left ventricular pacing output: effectiveness of stimulation and device longevity. Proceedings XIII International symposium on Progress in Clinical Pacing 145
Clinical management of atrial fibrillation: need for a comprehensive patient-centered approach. 145
Cardiac resynchronization therapy: effects on left and right ventricular ejection fraction during exercise. 145
Atrial fibrillation and heart failure: does one epidemic feed he other? 145
Neurohormones and inflammatory mediators in patients with heart failure undergoing cardiac resynchronization therapy: Time courses and prediction of response. 144
Confronto fra impedenziometria transtoracica ed ecocardiografia doppler nell'ottimizzazione della programmazione dell'intervallo ventricolo-ventricolare. 144
A new algorithm for ventricular capture detection in ICDs, in Proceedings XI International Symposium Progress in Clinical Pacing 144
Cardiac resynchronization therapy : effects on left and right ventricular ejection fraction during exercise 144
Valutazione angiocardioscintigrafica dei pazienti sottoposti aterapia di resincronizzazione cardiaca; esperienza del centro di Bologna. 143
Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society. 143
Targeting the arrhythmogenic substrate in atrial fibrillation: focus on structural remodeling 142
Evaluation of the atrial evoked response for capture detection with high-polarization leads. 141
Repolarization effects of multiple-cycle chemotherapy and predictors of QTc prolongation: A prospective female cohort study on >2000 ECGs 141
A controlled study on the effect of verapamil on atrial tachycaarrhythmias in patients with brady-tachy syndrome implanted with a DDDR pacemaker. 141
Decrease in patient radiation exposure by a tantalum filter during electrophysiological procedures. 140
A randomized comparison of amiodarone and class IC antiarrhythmic drugs to treat atrial fibrillation in patients paced for sinus node disease: the Prevention Investigation and Treatment: A Group for Observation and Research on Atrial arrhythmias (PITAGORA) trial. 139
QT interval shortening in spontaneous reports submitted to the FDA: the need for consensus 138
Role of atrial fibrillation after transcatheter closure of patent foramen ovale in patients with or without cryptogenic stroke 138
Practical management of ibrutinib in the real life: Focus on atrial fibrillation and bleeding 138
From lead management to implanted patient management: systematic review and meta-analysis of the last 15 years of experience in lead extraction 137
Algoritmi diagnostici nei defibrillatori mono e bicamerali: analisi delle capacità di discriminazione delle aritmie sopraventricolari e ventricolari. 137
Totale 19.071
Categoria #
all - tutte 151.935
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 151.935


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214.230 0 0 0 0 0 325 62 402 394 392 335 2.320
2021/20227.490 672 377 511 628 774 554 146 603 236 254 1.164 1.571
2022/20236.922 851 887 354 956 380 378 212 349 1.139 335 655 426
2023/20241.655 136 286 114 122 176 276 120 88 82 108 57 90
2024/20257.529 241 1.806 622 643 1.395 391 433 132 72 287 144 1.363
2025/202610.497 2.065 1.500 1.905 1.274 1.782 1.971 0 0 0 0 0 0
Totale 58.720